Scientific Core
Scientific Core
批准号:
10227135
负责人:
Kiran Bhaskar
金额:
$22.97万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2023-07-31
关键词:
AddressAffectAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosticAlzheimer&aposs disease related dementiaAlzheimer’s disease biomarkerAmerican IndiansAmyloidAmyloid beta-ProteinAreaAwardBiological AssayBiological MarkersBloodCancer CenterCaucasiansClinical ServicesCommunitiesCountryDataDementiaDepositionDiagnosisDiffusion Magnetic Resonance ImagingDiseaseEducationFundingFutureGoalsGrantImageImpaired cognitionIncidenceInflammatoryInstitutionLatinoLeadLeukoaraiosisLiquid substanceMagnetic Resonance ImagingMeasurementMetalloproteasesMethodsNerve DegenerationNew MexicoPathway interactionsPatientsPatternPhasePlayPopulationPopulations at RiskPredictive AnalyticsProtocols documentationResearchResearch PersonnelResourcesRiskRuralSamplingScientistServicesSocioeconomic StatusStandardizationStratificationTechnologyTestingUnited StatesUnited States National Institutes of HealthUniversitiesVascular DementiaVascular Diseasesbasebiomarker panelblood-brain barrier permeabilizationcerebrovascularclinical Diagnosiscohortcontrast enhanceddata sharingdementia riskendophenotypehealth care availabilityhealth disparityimaging capabilitiesimaging modalityimprovedinnovationneuroimagingnew technologynovelnovel markeroutreachpatient populationprogramsracial and ethnicracial diversityranpirnaserural Americansscreeningsocioeconomicsstudy populationtau Proteinstoolurban Native Americanwhite matter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – Scientific Core
In support of the New Mexico Exploratory Alzheimer’s Disease Research Center (NM eADRC), the Scientific
Core will centralize and expand existing expertise on Alzheimer’s disease biomarker research to the rural and
urban American Indian (AI) communities in New Mexico. Specifically, the Scientific Core will establish ADNI-
compatible, cerebrovascular focused neuroimaging, standardized assays for Aβ, tau and matrix
metalloproteases (MMPs) in the blood and CSF samples and developing predictive analytics to distinguish
different dementias in the rural and urban AI communities. Additional goals of the Scientific Core are to co-
ordinate with the administrative core to have the biomarker data deposited to NACC and NCRAD, provide
services to qualified investigators at University of New Mexico, across different institutions in the state and from
other ADRCs/institutions across the nation. The Scientific Core also propose to expand the pool of dementia
researchers by patterning with other centers/signature programs at the UNM and initiating new pilot programs
on novel biomarkers/pathways related to Alzheimer’s disease and related disorders (AD/ADRD) research. The
Scientific Core will support the NM eADRC to address one of the most important aspects of National
Alzheimer’s Project Act on health disparities by successfully performing endophenotyping of the ‘at risk’ AI
cohort. These goals will improve the limited screening clinical services available for dementia risk in AI
population and also increase the representation of AI population in dementia research. These goals will be
achieved by the Scientific Core under three specific aims. Aim 1: To provide expertise in magnetic resonance
imaging (MRI) methods for understanding vascular contributions to dementia in Alzheimer’s disease and
related disorders. Aim 2. To establish standardized assays for blood and CSF biomarker measurements for
the dementia diagnosis and to develop and develop/test novel biomarkers that are currently used in the NIH-
funded multi-center MarkVCID consortium study. Aim 3: Lead, coordinate, and develop dementia research
across UNM and around the state via partnerships and pilot grant funding to carryout AD/ADRD research.
Impact: Successful completion of all three specific aims of the Scientific Core will address one of the important
gaps of test establish relationship across diverse racial, ethnic and socioeconomic backgrounds for dementia
research, expand dementia research in NM and thus be ready for the P30 phase of ADRC in New Mexico in
the near future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of a novel tau clearance mechanism.
-
批准号:10445826
-
项目类别:
-
资助金额:$215.72万
-
财政年份:2022
-
负责人:Kiran Bhaskar
-
依托单位:
Scientific Core
-
批准号:10450035
-
项目类别:
-
资助金额:$39.1万
-
财政年份:2020
-
负责人:Kiran Bhaskar
-
依托单位:
Scientific Core
-
批准号:10038022
-
项目类别:
-
资助金额:$26.19万
-
财政年份:2020
-
负责人:Kiran Bhaskar
-
依托单位:
The Role of Inflammasome Signaling in Tauopathies
-
批准号:9887762
-
项目类别:
-
资助金额:$274.58万
-
财政年份:2020
-
负责人:Kiran Bhaskar
-
依托单位:
The role of inflammasome signaling in tauopathies
-
批准号:8693512
-
项目类别:
-
资助金额:$33.03万
-
财政年份:2014
-
负责人:Kiran Bhaskar
-
依托单位:
The role of inflammasome signaling in tauopathies
-
批准号:9230877
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2014
-
负责人:Kiran Bhaskar
-
依托单位:
The role of inflammasome signaling in tauopathies
-
批准号:8804963
-
项目类别:
-
资助金额:$33.03万
-
财政年份:2014
-
负责人:Kiran Bhaskar
-
依托单位:
The role of microglial- and neuron-specific MyD88 signaling in tauopathies
-
批准号:8382973
-
项目类别:
-
资助金额:$4.28万
-
财政年份:2012
-
负责人:Kiran Bhaskar
-
依托单位:
The role of microglial-and neuron-specific MyD88 signaling in tauopathies
-
批准号:8462009
-
项目类别:
-
资助金额:$18.21万
-
财政年份:2012
-
负责人:Kiran Bhaskar
-
依托单位:
The role of microglial-and neuron-specific MyD88 signaling in tauopathies
-
批准号:8546143
-
项目类别:
-
资助金额:$19.27万
-
财政年份:2012
-
负责人:Kiran Bhaskar
-
依托单位:
海外基金